Atmos Energy crews are continuing to work Saturday on a natural gas outage that started Thursday evening following a house ...

GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.

With the obesity numbers for Eli Lilly’s retatrutide already stacking up nicely, the company has rounded out its pitch for the triple agonist with top-line data on its ability to lower blood sugar ...

Eli Lilly disclosed that retatrutide, its experimental triple hormone receptor agonist, hit the primary and all key secondary ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Alto Neuroscience secures $120M to advance novel depression therapy ALTO-207 through Phase 3 trials, aiming for FDA ...

Eli Lilly has positive phase 3 results for its triple agonist retatrutide in type 2 diabetes (T2D) to go with its earlier encouraging data as a weight-loss therapy. The GIP, GLP-1 and glucagon agonist ...

India vs Afghanistan: The Board of Control for Cricket in India has opted for a high-intensity approach to the upcoming ...

Eledon Pharmaceuticals, Inc. is rated a Strong Buy following positive phase 2 BESTOW results for tegoprubart. Read more on ELDN stock here.

New analyses show DLB patients with lower plasma pTau181 levels - indicating an earlier stage of disease and absence of ...

The big week for Lamborghini Squadra Corse’s GT3 program has arrived, with Pfaff Motorsport set to give the Temerario GT3 its global race debut as part of IMSA’s GTD Pro field on Saturday at Sebring.

Researchers create a new polymer that mimics the mechanical, thermal, and electromagnetic properties of brain tissue, driving ...